Stay updated on Lenvatinib and Pembrolizumab in DTC Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib and Pembrolizumab in DTC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page revision tag was updated from Revision: v3.6.2 to Revision: v3.6.3, indicating a small housekeeping update to the page's metadata rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-07-04T03:55:26.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, signaling a minor maintenance update to the page version without altering study details.
    Difference
    0.0%
    Check dated 2026-06-27T01:23:36.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page's Study Documents section and several blocks listing study locations, investigators, and identifiers have been removed. This reduces visibility of critical trial materials and contact information, affecting the ability to review and engage with the study record.
    Difference
    19%
    Check dated 2026-06-19T23:46:03.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Added help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and header adjustments (Intervention/Treatment added; Intervention / Treatment removed) with Revision updated to v3.6.0, and the page now displays 'No longer looking for participants' to reflect closed enrollment.
    Difference
    0.4%
    Check dated 2026-06-12T17:28:39.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    A new page revision tag Revision: v3.5.5 was added, replacing the previous tag Revision: v3.5.4. This indicates an updated version of the page content or its documentation.
    Difference
    0.0%
    Check dated 2026-06-05T15:59:58.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The page's Revision tag was updated from v3.5.3 to v3.5.4, signaling a newer version of the page has been published. This is a metadata-level update and does not specify which content was modified.
    Difference
    0.0%
    Check dated 2026-05-15T05:51:45.000Z thumbnail image

Stay in the know with updates to Lenvatinib and Pembrolizumab in DTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.